Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity. 2009

Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
Faculty of Pharmaceutical Sciences, Hokuriku University, Kanagawa-machi, Kanazawa 920-1181, Japan.

This study on the structure-activity relationship of polymyxin B, a cyclic peptide antibiotic, used sixteen synthetic polymyxin B(3) analogs including alanine scanning analogs to elucidate the contribution of the side chains to antimicrobial activity and lipopolysaccharide (LPS) binding. Of these analogs, [Ala(5)]-polymyxin B(3) showed greatly reduced antimicrobial activity against Escherichia coli (E. coli), Salmonella Typhimurium (S. Typhimurium) and Pseudomonas aeruginosa (P. aeruginosa) with MIC values of 4-16 nmol/ml, suggesting that the Dab (alpha,gamma-diaminobutyric acid) residue at position 5 is the most important residue contributing to bactericidal activity. The antibacterial contribution of Dab when located within the lactam ring (positions 5, 8 and 9) was greater than when located outside the ring (positions 1 and 3). [D-Ala(6)]-, [L-Phe(6)]-, [Ala(7)]-, and [Gly(7)]-polymyxin B(3) analogs retained potent antimicrobial activity, indicating that neither the reduction of hydrophobic character of the D-Phe(6)-Leu(7) region nor the D-configuration at position 6 is indispensable for antimicrobial activity. LPS binding studies showed that decreased hydrophobicity of the lactam ring had little effect, but the N(gamma)-amino function of the Dab residues at position 1, 3, 5, 8 and 9 greatly affected LPS binding, with the contribution of Dab(5) being the most significant.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011112 Polymyxin B A mixture of polymyxins B1 and B2, obtained from BACILLUS POLYMYXA strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for treatment of infections with gram-negative bacteria, but may be neurotoxic and nephrotoxic. Aerosporin,Polymyxin B Sulfate
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D057927 Hydrophobic and Hydrophilic Interactions The thermodynamic interaction between a substance and WATER. Hydrophilic Interactions,Hydrophilic and Hydrophobic Interactions,Hydrophilicity,Hydrophobic Interactions,Hydrophobicity,Hydrophilic Interaction,Hydrophilicities,Hydrophobic Interaction,Hydrophobicities,Interaction, Hydrophilic,Interaction, Hydrophobic,Interactions, Hydrophilic,Interactions, Hydrophobic

Related Publications

Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
June 2007, Chinese journal of traumatology = Zhonghua chuang shang za zhi,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
February 2023, Journal of medicinal chemistry,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
October 1989, Antimicrobial agents and chemotherapy,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
May 2011, Nanotechnology,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
April 2011, Biochemistry,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
August 2014, Colloids and surfaces. B, Biointerfaces,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
January 2019, Frontiers in microbiology,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
February 1999, The Journal of antimicrobial chemotherapy,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
August 1978, Antibiotiki,
Kazushi Kanazawa, and Yuki Sato, and Kazuhiro Ohki, and Keiko Okimura, and Yoshiki Uchida, and Mitsuno Shindo, and Naoki Sakura
April 1980, Indian journal of biochemistry & biophysics,
Copied contents to your clipboard!